RFK Jr. Reportedly Continues Psychedelic Use Despite Cabinet Position
Robert F. Kennedy Jr. still uses psychedelics despite decades of sobriety, according to a forthcoming book. The claim comes from journalist Olivia Nuzzi, who reportedly had a romantic relationship with the current HHS Secretary.
Do you work in the ketamine industry? We launched the Healing Health Alliance, which is the first national provider network and GPO (Group Purchasing Organization) exclusively for ketamine practitioners and clinic owners. We will bring you significant cost savings and revenue generating opportunities. There’s no cost or obligation and you can join now!
Key Takeaways
| Topic | Details |
|---|---|
| Source | Olivia Nuzzi’s upcoming book “American Canto” |
| Substances Named | DMT and psychedelics generally |
| Legal Status | Psychedelics remain Schedule I under federal law |
| Kennedy’s Position | Secretary of Health and Human Services |
| Policy Stance | HHS committed to expanding psychedelic research |
Looking for treatment? Find ketamine clinics closest to you as well as other psychedelic therapies in your area.
The Book’s Claims
Nuzzi does not name Kennedy directly in her book. She refers to a “politician” she had a digital affair with during his 2023 presidential campaign. The New York Times reports that details strongly point to Kennedy as the subject.
The journalist writes that Kennedy shared his continued psychedelic use with her. He specifically mentioned smoking DMT, a powerful compound known for producing intense experiences that some describe as near death visions.
RELATED: These are the 7 Stages of a DMT Trip
A Legal Gray Area
Kennedy’s alleged use creates a unique situation. He heads the agency that oversees FDA drug policy. Psychedelics remain Schedule I substances, meaning they have no accepted medical use under current federal law.
Yet Kennedy has never hidden his interest in these substances. He recently told audiences about taking LSD at age 15. He said he had a “wonderful experience” and hoped to see dinosaurs from a comic book he enjoyed.
Policy Implications
The administration shows growing interest in psychedelic medicine. Kennedy, Vice President JD Vance, and the FDA commissioner attended a MAHA summit last week. The event featured a dedicated session on psychedelic therapy.
Kennedy announced ambitious goals in June. He said HHS is “absolutely committed” to expanding psychedelic research. He aims to provide legal access for military veterans within 12 months.
The tension between personal use and policy advocacy raises important questions. Can a cabinet member’s experience with psychedelics inform better health policy? Or does it undermine federal drug enforcement? These questions will likely shape the national conversation as the administration pushes forward with reform efforts.
